CM Life Sciences, Inc. (CMLFU) Financial Analysis & Valuation | Quarter Chart
CM Life Sciences, Inc. (CMLFU)
CMLFUPrice: $13
Fair Value: 🔒
🔒score
CM Life Sciences, Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.
CM Life Sciences, Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock ... more
Description
Shares
| Market Cap | $10.31B | Exchange | NASDAQ |
| Sector | Financial Services | Industry | Shell Companies |
| Country | US | CEO | Eli Decatur Casdin |
| IPO Date | 2020-09-02 | CAGR | — |
| Employees | — | Website | i.cmlifesciencesspac.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
CMLFU chart loading...
Fundamentals
Technicals
| Enterprise Value | $317.82M | P/E Ratio | -1444.44 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | — | P/B Ratio | 1.34 |
| P/CF Ratio | -36.55 | P/FCF Ratio | — |
| EPS | $-0.01 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 34.09% | Gross Margin | 0.7% |
| Operating Margin | -0.15% | Profit Margin | -0.18% |
| ROE | -0.28% | ROA | -0.15% |
| ROCE | -0.16% | Current Ratio | 3.09 |
| Quick Ratio | 2.95 | Cash Ratio | 1.07 |
| Debt/Equity | 0.28 | Interest Coverage | -55.84 |
| Altman Z Score | 21.5 | Piotroski Score | 3 |